% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • traderalph21 traderalph21 Feb 11, 2013 8:57 PM Flag

    The company knows EXACTLY where they are,

    leaving us to extrapolate things.

    As a result of recognizing revenue upon shipment of NUEDEXTA to its wholesalers and other customers, the Company recognized as a one-time adjustment to net product revenue of approximately $1.9 million in the second quarter of fiscal 2012, which was recorded as deferred revenue at December 31, 2011. This increase in net product revenue resulted in a reduction to net loss for the nine months ended June 30, 2012, of approximately $1.7 million, or a reduction to net loss per share of $0.01.

    The company books revenues on shipments to its customers! Everything else is a smoke screen.

    Sentiment: Buy